Expression of drug resistance protein related to Tc-99m MIBI breast imaging

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2021-2025

  Sun, Shung Shung ^a   Hsieh, Jih Fang ^b   Tsai, Shih Chuan ^c   Ho, Yung Jen ^d   Kao, Chia Hung ^e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI FOUNDATION HOSPITAL   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Drug resistance protein; Imaging; Tc 99m MIBI

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; KI 67 ANTIGEN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MUTANT PROTEIN; PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIODIAGNOSIS; TREATMENT FAILURE;

EID: 0033869098     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM and Pastan I: Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265-269, 1987.
2. Biedler J: Genetic aspects of multidrug resistance. Cancer 70: 1799-1809, 1992.
3. Baldini N, Scotlandi K, Barbanti-Brodano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S and Campanacci M et al: Expression of p-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 333: 1380-1385, 1995.
4. Nooter KA and Herweijer H: Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63: 663-669, 1991.
5. Kao CH, Wang S and Liu JC: The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432-436, 1994.
6. Del Vecchio S, Stoppelli P, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G and Esposito G et al: Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 53: 3198-3206, 1993.
7. Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI and Salvatore M: Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J Nucl Med 37: 665-672, 1996.
8. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA and Croop JM: Functional imaging of multidrug-resistance p-glycoprotein with an organotechnetium complex. Cancer Res 53: 977-984, 1993.
9. Rao VV, Chiu ML, Kronauge J and Piwnica-Worms D: Expression of recombinant human multidrug resistance p-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 35: 510-515, 1994.
10. Cordobes MD, Starzec A, Delmon-Moingeon L, Blanchot C, Kouyoumdjiam JC, Prevost G, Caglar MA and Moretti JL: Technetium-99m uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 37: 286-289, 1996.
11. Kostakoglu L, Elahi N, Kiratli P, Ruacan S, Sayek I, Baltali E, Sungur A, Hayran M and Bekdik CF: Clinical validation of influence of p-glycoprotein on the uptake of technetium-99m-sestamibi in patients with malignant tumors. J Nucl Med 38: 1003-1008, 1997.
12. Del Vecchio S, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, Thomas R, Cerra M, D'Aiuto G, Tsuruo T and Salvatore M: In vivo detection of multi-drug resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med 24: 150-159, 1997.
13. Bloom HJG and Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359, 1957.
14. Epstein J, Xiao HA Oba BK: P-glycoprotein expression in plasma cell mycloma is associated with resistance to VAD. Blood 74: 913-917, 1989.
15. Marie JP, Zittoun RA Sikic BI: Multidrug resistance (mdrl) gene expression in adult acute leukemias: correlation with treatment outcome and in vitro drug sensitivity. Blood 78: 586-592, 1991.